{
    "organizations": [],
    "uuid": "ccfb24ec544bec9d3adaf9bd4199d9fdd438dc59",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/shire-ma-takeda-pharma-bid/takeda-in-talks-with-shire-after-46-50-stg-shr-bid-rejected-idUSL8N1RW4GO",
    "ord_in_thread": 0,
    "title": "Takeda in talks with Shire after 46.50 stg/shr bid rejected",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "LONDON, April 19 (Reuters) - Japanâ€™s Takeda Pharmaceutical said on Thursday it was in negotiations with Shire after making a bid worth 46.50 pounds per share that was rejected by the London-listed rare diseases drugmaker.\nReuters first reported that Takeda had made the cash-and-stock takeover offer, valuing Shire at around $61 billion. (Reporting by Ben Hirschler; Editing by Susan Fenton)\n ",
    "published": "2018-04-19T20:23:00.000+03:00",
    "crawled": "2018-04-20T11:48:35.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "london",
        "april",
        "reuters",
        "japan",
        "takeda",
        "pharmaceutical",
        "said",
        "thursday",
        "negotiation",
        "shire",
        "making",
        "bid",
        "worth",
        "pound",
        "per",
        "share",
        "rejected",
        "rare",
        "disease",
        "drugmaker",
        "reuters",
        "first",
        "reported",
        "takeda",
        "made",
        "takeover",
        "offer",
        "valuing",
        "shire",
        "around",
        "billion",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "susan",
        "fenton"
    ]
}